Pen Tsao Chemical Industry Ltd

Exhibitor at CPHI Frankfurt 2022 stand 120D52, API
About Us

PEN TSAO CHEMICAL INDUSTRY LTD.  serves the International Pharma Industry since 1995. Our strengths are Development and Production of Niche API’s, Specialties and Key API Intermediates for the International and Domestic Market.
Mission Statement We are a renowned manufacturer of Active Pharmaceutical Ingredients, Advanced Intermediates and High End Fine Chemicals and provide a broad range of products, services and technologies to our customers. •As a reliable partner with a high quality awareness, state-of-the-art technology and highly skilled personnel, Pen Tsao Group delivers added value products and services.

Strategic Focus Innovative Pharmaceutical Industry (Custom Manufacturing) •Generic Pharmaceutical Industry (FDF, API and Custom Manufacturing) •High End Fine Chemicals Industry (Catalogue Products, Custom Manufacturing)
Rodallis Biopharma Co., Ltd. located ~75 km south of Shanghai City center is current under construction with future API capacity of 270 ton and 70...

  • HK
  • 2015
    On CPHI since
  • 2
  • 100 - 249
Company types
Pharmaceutical company
Primary activities
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
  • 27B, CKK Commercial Centre, 289 Hennessy Road, Wan Chai, Hong Kong, S.A.R., China
Event information
CPHI Frankfurt 2022
  • 1-3 November 2022
  • Messe Frankfurt, Germany
  • Visit us at stand 120D52, API

Products Featured at CPHI Frankfurt 2022

  • Loxoprofen Sodium

    Product Loxoprofen Sodium

    Loxoprofen Sodium sold mainly as Loxoprofen Sodium Dihydrate (CAS:226721-96-6).  Registration in Japan, Korea, China. Specifications: JP, KP, CP, In-house
  • Ethionamide

    Product Ethionamide

    Ethionamide belongs to the secondary MDR Anti-TB drugs used in the fight against Tuberculosis. WHO prequalified API since 2013. Registrations in India, Russia, Ukraine. Specifications: EP, EPW, IP, USP, In-house. 
  • Bucillamine

    Product Bucillamine

    Bucillamine is an antirheumatic agent.  It is mainly used in Japan and Korea. Activity is mediated by the two thiol groups that the molecule contains. Research done in USA showed positive transplant preservation properties. Bucillamine has been used in trials studying the tr...
  • Clofazimine

    Product Clofazimine

    Clofazimine is a phenazine dye with anti-mycobacterial and anti-inflammatory activities.Clofazimine is used to treat Leprosis and is active against various other Mycobacteria. WHO recommends its for the treatment of MDR & XDR Tuberculosis. WHO Prequalification in progress. Specifications: EP, US...
  • Prothionamide

    Product Prothionamide

    Protionamide is a thioamide derivative with antitubercular activity, belongs to the secondary MDR Anti-TB drugs used in the fight against Tuberculosis. WHO prequalified API since 2013. Registrations in China, India, Germany, Ukraine. Specifications: BP, BPD, BPD-W, CP, IP, In-house.